There is room for additional content. This shouldn’t be longer that a couple of sentences. Make sure to check the amount of characters. Dit is een link
A valuable network of locally connected science clusters enhances proximity to various resources. Our Global Connectivity adds an extra dimension to our specialised assets in local clusters by providing opportunities to connect with others from our global network.
Connectivity leverages the full power of our network of science clusters to support growth for our clients.
A valuable network of locally connected science clusters enhances proximity to various resources. Our Global Connectivity adds an extra dimension to our specialised assets in local clusters by providing opportunities to connect with others from our global network.
Connectivity leverages the full power of our network of science clusters to support growth for our clients.
Life sciences and health (LSH) are essential to shaping our environment and lifestyles, tackling global challenges like climate change and the profound effects of (bio)genetics on humanity. Today, countless opportunities exist for us to better understand our bodies and the world around us. The question is: why not connect and explore these possibilities?
The dynamic LSH sector is driving groundbreaking research – from using Artificial Intelligence (AI) to target cancer cells, to mapping out diseases such as dementia and autoimmune disorders. It encompasses innovations in biogenetics, genetics, and even explores alternative energy sources and new materials.
INTROTEXT: Our core values are connect, collaborate and innovate. Our core values are connect, collaborate and innovate. Our core values are connect, collaborate and innovate.
We believe in connecting people with shared goals and ambitions. We actively organise oppurtunities for them to meet and foster our community to enable meaningful conversations and lasting relationships. In collaboration with our partners, the Kadans community supports and strengthens the innovation ecosystem.
We believe in connecting people with shared goals and ambitions. We actively organise oppurtunities for them to meet and foster our community to enable meaningful conversations and lasting relationships. In collaboration with our partners, the Kadans community supports and strengthens the innovation ecosystem.
Being close to resources, scientists, and companies in life sciences and health is crucial for research success. Our science clusters provide close proximity, making it easier to connect with like-minded professionals and access fresh ideas. This proximity ensures you can find the talent, capital, and expertise you need.
By being situated in these vibrant hubs, you benefit from immediate access to a network of researchers and organisations, enhancing your chances of achieving your goals.
Being close to resources, scientists, and companies in life sciences and health is crucial for research success. Our science clusters provide close proximity, making it easier to connect with like-minded professionals and access fresh ideas. This proximity ensures you can find the talent, capital, and expertise you need.
By being situated in these vibrant hubs, you benefit from immediate access to a network of researchers and organisations, enhancing your chances of achieving your goals.
Being close to resources, scientists, and companies in life sciences and health is crucial for research success. Our science clusters provide close proximity, making it easier to connect with like-minded professionals and access fresh ideas. This proximity ensures you can find the talent, capital, and expertise you need.
By being situated in these vibrant hubs, you benefit from immediate access to a network of researchers and organisations, enhancing your chances of achieving your goals.
Being close to resources, scientists, and companies in life sciences and health is crucial for research success. Our science clusters provide close proximity, making it easier to connect with like-minded professionals and access fresh ideas. This proximity ensures you can find the talent, capital, and expertise you need.
By being situated in these vibrant hubs, you benefit from immediate access to a network of researchers and organisations, enhancing your chances of achieving your goals.
Being close to resources, scientists, and companies in life sciences and health is crucial for research success. Our science clusters provide close proximity, making it easier to connect with like-minded professionals and access fresh ideas. This proximity ensures you can find the talent, capital, and expertise you need.
By being situated in these vibrant hubs, you benefit from immediate access to a network of researchers and organisations, enhancing your chances of achieving your goals.
Being close to resources, scientists, and companies in life sciences and health is crucial for research success. Our science clusters provide close proximity, making it easier to connect with like-minded professionals and access fresh ideas. This proximity ensures you can find the talent, capital, and expertise you need.
By being situated in these vibrant hubs, you benefit from immediate access to a network of researchers and organisations, enhancing your chances of achieving your goals.
Discover the advantages of each location and find the perfect environment for your business.
At Kadans, we bring innovators together to tackle global challenges. By investing in and developing specialised spaces across Europe’s leading science clusters, we provide more than just workspaces—we offer access to the talent, resources, and networks needed to drive success.
Whether in Life Sciences & Health, Food, Energy, or the Digital Economy, we connect you with the right people and organisations to help you grow, innovate, and change the world.
At Kadans, the Advanced Molecular and Cellular Mechanisms cluster stands out with the groundbreaking work of Prof. dr. Sonja Zweegman. Her innovative approach to developing treatments for multiple myeloma could revolutionise the field. Prof. Zweegman’s team has pioneered the CCR-CAR T cell, a novel technique that enhances CAR T cells with an additional ‘antenna’ to improve tumour cell binding and elimination.
Explore more about how our Advanced Molecular & Cellular Mechanisms cluster is driving innovation and learn about other collaborative clusters in The Netherlands and UK.
Explore more about how our Advanced Molecular & Cellular Mechanisms cluster is driving innovation and learn about other collaborative clusters in The Netherlands and UK.
At Kadans, the Advanced Molecular and Cellular Mechanisms cluster stands out with the groundbreaking work of Prof. dr. Sonja Zweegman. Her innovative approach to developing treatments for multiple myeloma could revolutionise the field. Prof. Zweegman’s team has pioneered the CCR-CAR T cell, a novel technique that enhances CAR T cells with an additional ‘antenna’ to improve tumour cell binding and elimination.
At Kadans, the Advanced Molecular and Cellular Mechanisms cluster stands out with the groundbreaking work of Prof. dr. Sonja Zweegman. Her innovative approach to developing treatments for multiple myeloma could revolutionise the field. Prof. Zweegman’s team has pioneered the CCR-CAR T cell, a novel technique that enhances CAR T cells with an additional ‘antenna’ to improve tumour cell binding and elimination.
At Kadans, the Advanced Molecular and Cellular Mechanisms cluster stands out with the groundbreaking work of Prof. dr. Sonja Zweegman. Her innovative approach to developing treatments for multiple myeloma could revolutionise the field. Prof. Zweegman’s team has pioneered the CCR-CAR T cell, a novel technique that enhances CAR T cells with an additional ‘antenna’ to improve tumour cell binding and elimination.
Explore more about how our Advanced Molecular & Cellular Mechanisms cluster is driving innovation and learn about other collaborative clusters in The Netherlands and UK.
At Kadans, the Advanced Molecular and Cellular Mechanisms cluster stands out with the groundbreaking work of Prof. dr. Sonja Zweegman. Her innovative approach to developing treatments for multiple myeloma could revolutionise the field. Prof. Zweegman’s team has pioneered the CCR-CAR T cell, a novel technique that enhances CAR T cells with an additional ‘antenna’ to improve tumour cell binding and elimination.
Explore more about how our Advanced Molecular & Cellular Mechanisms cluster is driving innovation and learn about other collaborative clusters in The Netherlands and UK.
At Kadans, the Advanced Molecular and Cellular Mechanisms cluster stands out with the groundbreaking work of Prof. dr. Sonja Zweegman. Her innovative approach to developing treatments for multiple myeloma could revolutionise the field. Prof. Zweegman’s team has pioneered the CCR-CAR T cell, a novel technique that enhances CAR T cells with an additional ‘antenna’ to improve tumour cell binding and elimination.
Explore more about how our Advanced Molecular & Cellular Mechanisms cluster is driving innovation and learn about other collaborative clusters in The Netherlands and UK.
Explore more about how our Advanced Molecular & Cellular Mechanisms cluster is driving innovation and learn about other collaborative clusters in The Netherlands and UK.
At Kadans, the Advanced Molecular and Cellular Mechanisms cluster stands out with the groundbreaking work of Prof. dr. Sonja Zweegman. Her innovative approach to developing treatments for multiple myeloma could revolutionise the field. Prof. Zweegman’s team has pioneered the CCR-CAR T cell, a novel technique that enhances CAR T cells with an additional ‘antenna’ to improve tumour cell binding and elimination.
At Kadans, the Advanced Molecular and Cellular Mechanisms cluster stands out with the groundbreaking work of Prof. dr. Sonja Zweegman. Her innovative approach to developing treatments for multiple myeloma could revolutionise the field. Prof. Zweegman’s team has pioneered the CCR-CAR T cell, a novel technique that enhances CAR T cells with an additional ‘antenna’ to improve tumour cell binding and elimination.
At Kadans, the Advanced Molecular and Cellular Mechanisms cluster stands out with the groundbreaking work of Prof. dr. Sonja Zweegman. Her innovative approach to developing treatments for multiple myeloma could revolutionise the field. Prof. Zweegman’s team has pioneered the CCR-CAR T cell, a novel technique that enhances CAR T cells with an additional ‘antenna’ to improve tumour cell binding and elimination.
Explore more about how our Advanced Molecular & Cellular Mechanisms cluster is driving innovation and learn about other collaborative clusters in The Netherlands and UK.
At Kadans, the Advanced Molecular and Cellular Mechanisms cluster stands out with the groundbreaking work of Prof. dr. Sonja Zweegman. Her innovative approach to developing treatments for multiple myeloma could revolutionise the field. Prof. Zweegman’s team has pioneered the CCR-CAR T cell, a novel technique that enhances CAR T cells with an additional ‘antenna’ to improve tumour cell binding and elimination.
Explore more about how our Advanced Molecular & Cellular Mechanisms cluster is driving innovation and learn about other collaborative clusters in The Netherlands and UK.
At Kadans, the Advanced Molecular and Cellular Mechanisms cluster stands out with the groundbreaking work of Prof. dr. Sonja Zweegman. Her innovative approach to developing treatments for multiple myeloma could revolutionise the field. Prof. Zweegman’s team has pioneered the CCR-CAR T cell, a novel technique that enhances CAR T cells with an additional ‘antenna’ to improve tumour cell binding and elimination.
Explore more about how our Advanced Molecular & Cellular Mechanisms cluster is driving innovation and learn about other collaborative clusters in The Netherlands and UK.
Explore more about how our Advanced Molecular & Cellular Mechanisms cluster is driving innovation and learn about other collaborative clusters in The Netherlands and UK.
At Kadans, the Advanced Molecular and Cellular Mechanisms cluster stands out with the groundbreaking work of Prof. dr. Sonja Zweegman. Her innovative approach to developing treatments for multiple myeloma could revolutionise the field. Prof. Zweegman’s team has pioneered the CCR-CAR T cell, a novel technique that enhances CAR T cells with an additional ‘antenna’ to improve tumour cell binding and elimination.
At Kadans, the Advanced Molecular and Cellular Mechanisms cluster stands out with the groundbreaking work of Prof. dr. Sonja Zweegman. Her innovative approach to developing treatments for multiple myeloma could revolutionise the field. Prof. Zweegman’s team has pioneered the CCR-CAR T cell, a novel technique that enhances CAR T cells with an additional ‘antenna’ to improve tumour cell binding and elimination.
At Kadans, the Advanced Molecular and Cellular Mechanisms cluster stands out with the groundbreaking work of Prof. dr. Sonja Zweegman. Her innovative approach to developing treatments for multiple myeloma could revolutionise the field. Prof. Zweegman’s team has pioneered the CCR-CAR T cell, a novel technique that enhances CAR T cells with an additional ‘antenna’ to improve tumour cell binding and elimination.
Explore more about how our Advanced Molecular & Cellular Mechanisms cluster is driving innovation and learn about other collaborative clusters in The Netherlands and UK.
At Kadans, the Advanced Molecular and Cellular Mechanisms cluster stands out with the groundbreaking work of Prof. dr. Sonja Zweegman. Her innovative approach to developing treatments for multiple myeloma could revolutionise the field. Prof. Zweegman’s team has pioneered the CCR-CAR T cell, a novel technique that enhances CAR T cells with an additional ‘antenna’ to improve tumour cell binding and elimination.
Explore more about how our Advanced Molecular & Cellular Mechanisms cluster is driving innovation and learn about other collaborative clusters in The Netherlands and UK.
At Kadans, the Advanced Molecular and Cellular Mechanisms cluster stands out with the groundbreaking work of Prof. dr. Sonja Zweegman. Her innovative approach to developing treatments for multiple myeloma could revolutionise the field. Prof. Zweegman’s team has pioneered the CCR-CAR T cell, a novel technique that enhances CAR T cells with an additional ‘antenna’ to improve tumour cell binding and elimination.
Explore more about how our Advanced Molecular & Cellular Mechanisms cluster is driving innovation and learn about other collaborative clusters in The Netherlands and UK.
Explore more about how our Advanced Molecular & Cellular Mechanisms cluster is driving innovation and learn about other collaborative clusters in The Netherlands and UK.
At Kadans, the Advanced Molecular and Cellular Mechanisms cluster stands out with the groundbreaking work of Prof. dr. Sonja Zweegman. Her innovative approach to developing treatments for multiple myeloma could revolutionise the field. Prof. Zweegman’s team has pioneered the CCR-CAR T cell, a novel technique that enhances CAR T cells with an additional ‘antenna’ to improve tumour cell binding and elimination.
At Kadans, the Advanced Molecular and Cellular Mechanisms cluster stands out with the groundbreaking work of Prof. dr. Sonja Zweegman. Her innovative approach to developing treatments for multiple myeloma could revolutionise the field. Prof. Zweegman’s team has pioneered the CCR-CAR T cell, a novel technique that enhances CAR T cells with an additional ‘antenna’ to improve tumour cell binding and elimination.
At Kadans, the Advanced Molecular and Cellular Mechanisms cluster stands out with the groundbreaking work of Prof. dr. Sonja Zweegman. Her innovative approach to developing treatments for multiple myeloma could revolutionise the field. Prof. Zweegman’s team has pioneered the CCR-CAR T cell, a novel technique that enhances CAR T cells with an additional ‘antenna’ to improve tumour cell binding and elimination.
Explore more about how our Advanced Molecular & Cellular Mechanisms cluster is driving innovation and learn about other collaborative clusters in The Netherlands and UK.
At Kadans, the Advanced Molecular and Cellular Mechanisms cluster stands out with the groundbreaking work of Prof. dr. Sonja Zweegman. Her innovative approach to developing treatments for multiple myeloma could revolutionise the field. Prof. Zweegman’s team has pioneered the CCR-CAR T cell, a novel technique that enhances CAR T cells with an additional ‘antenna’ to improve tumour cell binding and elimination.
Explore more about how our Advanced Molecular & Cellular Mechanisms cluster is driving innovation and learn about other collaborative clusters in The Netherlands and UK.
The Advanced Molecular and Cellular Mechanisms cluster is proud to have Prof. dr. Sonja Zweegman as one of its key figures. Known for her groundbreaking work in the treatment of multiple myeloma, Prof. Zweegman is revolutionising the field with a novel approach that aims to develop therapies independently from the pharmaceutical industry—and potentially in record time.
Hier is ruimte voor een stukje tekst.
Discover the advantages of each location and find the perfect environment for your business to thrive.
Sluit je aan bij deze vooruitstrevende bedrijven
Bel, mail of chat met Rik
Bel, mail of chat met Rik
Bel, mail of chat met Rik
Bel, mail of chat met Rik
Bel, mail of chat met Rik
The key to a successful science cluster is the presence of economic, physical and network drivers.
The key to a successful science cluster is the presence of economic, physical and network drivers.
Hier is ruimte voor text.
Hier is ruimte voor text.
Hier is ruimte voor text.
Hier is ruimte voor text.
Hier is ruimte voor text.
The key to a successful science cluster is the presence of economic, physical and network drivers.
Welcome to Lorem Ipsum – the ultimate placeholder text solution for your design and communication needs. Lorem Ipsum is a dummy text used by designers, printers, and typesetters for decades to demonstrate the visual effects of different typefaces and layouts.
Hier kan een tekst staan.
